PARP1 and prostate carcinoma: Furthermore, knock-down of PRKAR2B in DU-145 cell using siRNA increased the expression of cleaved PARP (Figure 5A, left panel), a cell apoptosis marker, indicating PRKAR2B is required for prostate cancer cell survival and knockdown of PRKAR2B expression will induce cell apoptosis.